With a mission to create the most advanced digital diagnostic laboratory network enabling the connected world and to provide telemedicine and instant care, DIVOC Health launched its first, one-of-a-kind, technologically advanced DIVOC Laboratories in New Delhi in August 2020.
Within a month of its establishment, DIVOC Lab in New Delhi has over 100 patients each day and aims to be of assistance to 500-600 patients daily by the next 90 days. The Laboratory has already been accredited by NABL and ICMR and have all tests and diagnosis available including Covid19.
Backed by venture capitalist impact financing from London, England DIVOC Wellness is reportedly preparing to open 20 labs across Tier 2 and Tier 3 cities like Lucknow, Bhopal and Jaipur, etc.
The focus of the expansion will be on developing more number of ‘Labs of the Future’ where the company claims that patients get diagnostics tests and results delivered to their homes, with accuracy, in less than 20 minutes.
Dr Kanav Kahol, CEO, DIVOC Health, said, “We are working on a unique platform that will allow phlebotomists to double their income. We aim to provide a modern, quality driven digital approach to laboratory operations that facilitate consumers with unprecedented reliability, convenience, and impactful innovations. We have actually seen a demand increase for innovations and we promise to be digitally empowered, bring innovations to improve health and be trustworthy and responsible for our operations. For telemedicine to be successful it is important to have equally faster diagnostics at the doorstep, just as instant as virtual health consultations are. We have plans to establish 20 Divoc Labs in India within this year.”
DIVOC Lab’s facility in Okhla, New Delhi reportedly offers Clinical Chemistry, Clinical Microbiology, Hematology, Serology, Clinical Microscopy, Cytopathology and Molecular Biology. It also offers TRUNAAT, RT PCR and Antigen COVID Testing pending ICMR notifications and approvals. DIVOC recently partnered with Atomo Diagnostics to sell Atomo’s COVID-19 rapid antibody test in India.